The rationale is based upon averting the immunosuppression of effector T-cell function by PD-L1 and sequestering TGF-β (secreted by malignant cells, MDSCs, and Treg cells), hence preventing TGF-β-mediated tumor development and metastasis (111). This evidence concerns the gene TGFB1 and neoplasm.